Sight Sciences wins $34M patent verdict against Alcon over Hydrus Microstent

Sight Sciences, Inc.

Jury found Alcon willfully infringed three Sight Sciences patents (U.S. 8,287,482, 9,370,443, 11,389,328) related to Hydrus Microstent.
Verdict awards $34M: $5.5M lost profits + $28.5M royalties for sales from commercial launch through trial.
Verdict subject to appeal; judge may later enhance damages for willfulness.
Case filed September 2021 in U.S. District Court for Delaware; trial lasted five days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.